ALPS Medical Breakthroughs ETF (SBIO) Price, Holdings, & News

ETF Overview

The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.

Key Stats

• Today's Range: $34.61 to $35.08
• 50-Day Range: $29.94 to $35.05
• 52-Week Range: $22.33 to $42.73
• Volume: 5,213 shs
• Average Volume: 14,182 shs
• Market Capitalization: $82.37 million
• Assets Under Management: $81.37 million
• Dividend Yield: 3.34%
• Net Expense Ratio: 0.50%
• Aggregate Rating: Moderate Buy

SBIO ETF - Frequently Asked Questions

How have SBIO shares performed this year?

ALPS Medical Breakthroughs ETF's stock was trading at $33.03 at the start of the year. Since then, SBIO shares have increased by 6.1% and is now trading at $35.05.

Who are ALPS Medical Breakthroughs ETF's major shareholders?

Top institutional shareholders of ALPS Medical Breakthroughs ETF include DAVENPORT & Co LLC (28.57%), Bank of America Corp DE (2.29%), Strategic Financial Services Inc. (1.58%) and Phoenix Wealth Advisors (1.09%).

How do I buy shares of ALPS Medical Breakthroughs ETF?

Shares of SBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of ALPS Medical Breakthroughs ETF own?

Based on aggregate information from My MarketBeat watchlists, some other companies that ALPS Medical Breakthroughs ETF investors own include Waste Connections (WCN), American Water Works (AWK), iShares Micro-Cap ETF (IWC), The RMR Group (RMR), AU Optronics (AUOTY), DiamondRock Hospitality (DRH) and Triple Flag Precious Metals (TFPM).

Fund Details

• Issuer: ALPS
• Fund Name: ALPS Medical Breakthroughs ETF
• Tax Classification: Regulated Investment Company
• Stock Exchange: NYSEARCA
• Current Symbol: NYSEARCA:SBIO
• Inception Date: 12/31/2014
• Fund Manager: Ryan Mischker, Andrew Hicks
• Web: N/A
• Phone: N/A

Fund Focus

• Asset Class: Equity
• Benchmark: S-Network Medical Breakthroughs Index
• Category: Sector
• Focus: Health Care
• Development Level: Developed Markets
• Region: North America
• Number of Holdings: 109

Fund Statistics

• Assets Under Management: $81.37 million
• Average Daily Volume: $6.86 thousand
• Discount/Premium: 0.02%

Administrator, Advisor and Custodian

• Administrator: ALPS Fund Services, Inc.
• Advisor: ALPS Advisors, Inc.
• Custodian: State Street Bank and Trust Company
• Distributor: ALPS Distributors, Inc.
• Transfer Agent: State Street Bank and Trust Company
• Trustee: N/A
• Lead Market Maker: GTS

Options

• Optionable: Optionable
• Options Volume: 2
• Put Options: 8
• Call Options: 2
• Short Interest: 15,700 shs

Miscellaneous

• Outstanding Shares: 2,350,000
• Beta: 0.92
• Creation Unit: 50,000
• Creation Fee: $500.00